Production (Stage)
Connect Biopharma Holdings Limited
CNTB
$0.9301
-$0.0199-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 12.06M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 12.06M | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 12.06M | -- |
| SG&A Expenses | -- | -- | -- | 15.64M | 15.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 83.00K | 684.00K |
| Total Operating Expenses | -- | -- | -- | 57.41M | 65.00M |
| Operating Income | -- | -- | -- | -45.35M | -65.00M |
| Income Before Tax | -- | -- | -- | -36.38M | -55.44M |
| Income Tax Expenses | -- | -- | -- | 116.00K | 118.00K |
| Earnings from Continuing Operations | -- | -- | -- | -36.50 | -55.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -36.50M | -55.56M |
| EBIT | -- | -- | -- | -45.35M | -65.00M |
| EBITDA | -- | -- | -- | -44.66M | -64.31M |
| EPS Basic | -- | -- | -- | -0.66 | -1.01 |
| Normalized Basic EPS | -- | -- | -- | -0.41 | -0.63 |
| EPS Diluted | -- | -- | -- | -0.67 | -1.01 |
| Normalized Diluted EPS | -- | -- | -- | -0.41 | -0.63 |
| Average Basic Shares Outstanding | -- | -- | -- | 220.41M | 220.32M |
| Average Diluted Shares Outstanding | -- | -- | -- | 220.82M | 220.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |